Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Antiplatelet Therapy and Cardiovascular Diseases, Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research, and Venous Thromboembolism Diagnosis and Management.
Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors.
A multicentre observational study on landiolol use, efficacy, and safety in European patients with supraventricular arrhythmia (Landi-UP).
Impact of direct oral anticoagulants on target lesion revascularization rates in patients with chronic coronary syndrome.
Plasma metabolomic profiling of patients with acute coronary syndrome treated with potent platelet inhibitors.
Effect of Intramuscular Adrenaline on Histamine-Induced Hypotension: A Randomised Placebo-Controlled Pilot Trial.
Correction: Sirtuins and regulatory miRNAs as epigenetic determinants of empagliflozin-mediated recovery after acute myocardial infarction.
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy.
Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study.
Sirtuins and regulatory miRNAs as epigenetic determinants of empagliflozin-mediated recovery after acute myocardial infarction.
The quality of care and long-term mortality of out of hospital cardiac arrest survivors after acute myocardial infarction: a nationwide cohort study.
One-year clinical outcomes in patients with acute coronary syndrome treated with clopidogrel versus prasugrel versus ticagrelor: Results of the Polish Registry of Acute Coronary Syndromes (PL-ACS).
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis.
Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.
Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint.
2023 ESC Guidelines for the management of acute coronary syndromes.
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
Landiolol for refractory ventricular fibrillation in out-of-hospital cardiac arrest: A randomized, double-blind, placebo-controlled, pilot trial.
Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trial.
Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation.
Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry
Alteration of circulating ACE2-network related microRNAs in patients with COVID-19.
Ticagrelor downregulates the expression of proatherogenic and proinflammatory miR125-b compared to clopidogrel: A randomized, controlled trial.
The quality of care and long-term mortality of out of hospital cardiac arrest survivors after acute myocardial infarction: a nationwide cohort study
Abbreviated dual antiplatelet therapy after acute coronary syndrome.